Search Prime Grants

U54HL143541

Cooperative Agreement

Overview

Grant Description
The center for advancing point of care in heart, lung, blood and sleep diseases.
Awardee
University Of Massachusetts Medical School
Funding Goals
TO FOSTER HEART AND VASCULAR RESEARCH IN THE BASIC, TRANSLATIONAL, CLINICAL AND POPULATION SCIENCES, AND TO FOSTER TRAINING TO BUILD TALENTED YOUNG INVESTIGATORS IN THESE AREAS, FUNDED THROUGH COMPETITIVE RESEARCH TRAINING GRANTS. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, USE SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, FOSTER AND ENCOURAGE PARTICIPATION IN INNOVATION AND ENTREPRENEURSHIP BY SOCIALLY AND ECONOMICALLY DISADVANTAGED PERSONS, AND INCREASE PRIVATE-SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT FUNDING. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE TECHNOLOGICAL INNOVATION, FOSTER TECHNOLOGY TRANSFER THROUGH COOPERATIVE R&D BETWEEN SMALL BUSINESSES AND RESEARCH INSTITUTIONS, AND INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL R&D.
Grant Program (CFDA)
93.837 - Cardiovascular Diseases Research
Awarding / Funding Agency
National Heart Lung and Blood Institute (NHLBI) [HHS - NIH]
Place of Performance
Worcester, Massachusetts 01655 United States
Geographic Scope
Single Zip Code
Related Opportunity
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional) (PAR-22-203)
Analysis Notes
COVID-19 $124,298,473 (90%) percent of this Cooperative Agreement was funded by COVID-19 emergency acts including the American Rescue Plan Act of 2021 and the Paycheck Protection Program and Health Care Enhancement Act.
Amendment Since initial award the End Date has been extended from 06/30/23 to 08/31/28 and the total obligations have increased 10835% from $1,256,113 to $137,353,442.
University Of Massachusetts Medical School was awarded Clinical Studies Core Cooperative Agreement U54HL143541 worth $137,353,442 from National Heart Lung and Blood Institute in August 2018 with work to be completed primarily in Worcester Massachusetts United States. The grant has a duration of 10 years and was awarded through assistance program 93.837 Cardiovascular Diseases Research. The Cooperative Agreement was awarded through grant opportunity Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 8/20/25

Period of Performance
8/22/18
Start Date
8/31/28
End Date
70.0% Complete

Funding Split
$137.4M
Federal Obligation
$0.0
Non-Federal Obligation
$137.4M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54HL143541

Subgrant Awards

Disclosed subgrants for U54HL143541

Transaction History

Modifications to U54HL143541

Additional Detail

Award ID FAIN
U54HL143541
SAI Number
U54HL143541-2501611005
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Funding Office
75NH00 NIH National Heart, Lung, and Blood Institute
Awardee UEI
MQE2JHHJW9Q8
Awardee CAGE
6R004
Performance District
MA-02
Senators
Edward Markey
Elizabeth Warren

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Health and Human Services (075-0898) Health research and training Grants, subsidies, and contributions (41.0) $123,051,876 91%
National Heart, Lung, and Blood Institute, National Institutes of Health, Health and Human Services (075-0872) Health research and training Grants, subsidies, and contributions (41.0) $10,465,851 8%
Modified: 8/20/25